Edmond DE Rothschild Holding S.A. Has $1.11 Million Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Edmond DE Rothschild Holding S.A. cut its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 23.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 14,159 shares of the company’s stock after selling 4,231 shares during the quarter. Edmond DE Rothschild Holding S.A.’s holdings in GE HealthCare Technologies were worth $1,107,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of GEHC. Cherry Creek Investment Advisors Inc. boosted its position in GE HealthCare Technologies by 0.3% during the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock valued at $2,920,000 after purchasing an additional 114 shares during the last quarter. Independence Bank of Kentucky boosted its holdings in shares of GE HealthCare Technologies by 6.0% in the 4th quarter. Independence Bank of Kentucky now owns 2,018 shares of the company’s stock valued at $158,000 after buying an additional 114 shares during the last quarter. Haverford Trust Co grew its stake in shares of GE HealthCare Technologies by 2.4% in the fourth quarter. Haverford Trust Co now owns 4,896 shares of the company’s stock valued at $383,000 after buying an additional 115 shares in the last quarter. Tandem Capital Management Corp ADV increased its holdings in GE HealthCare Technologies by 0.4% during the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock worth $2,205,000 after buying an additional 118 shares during the last quarter. Finally, Arcus Capital Partners LLC raised its position in GE HealthCare Technologies by 3.0% during the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company’s stock worth $322,000 after acquiring an additional 119 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $79.57 on Wednesday. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The firm’s 50-day simple moving average is $86.46 and its 200 day simple moving average is $85.76. The firm has a market cap of $36.39 billion, a price-to-earnings ratio of 18.38, a P/E/G ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.18%. GE HealthCare Technologies’s payout ratio is 3.23%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Wells Fargo & Company upped their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price target for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, two have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $97.73.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.